| |
 |
|
Class Information
Number: 514/313
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Polycyclo ring system having the six-membered hetero ring as one of the cyclos > Bicyclo ring system having the six-membered hetero ring as one of the cyclos > Quinolines (including hydrogenated) > Nitrogen, other than as nitro or nitroso, attached directly to the six membered hetero ring by nonionic bonding
Description: Subject matter wherein nitrogen, except as a member of the nitro (-NO2
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618986 |
Method of treating latent tuberculosis |
Nov. 17, 2009 |
| 7608628 |
Alkylsulphonamide quinolines |
Oct. 27, 2009 |
| 7585878 |
Benzamide derivative or salt thereof |
Sep. 8, 2009 |
| 7576099 |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
Aug. 18, 2009 |
| 7572806 |
PPAR active compounds |
Aug. 11, 2009 |
| 7563804 |
FMF treatment |
Jul. 21, 2009 |
| 7550481 |
Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease |
Jun. 23, 2009 |
| 7550482 |
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
Jun. 23, 2009 |
| 7550483 |
Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinoli- necarboxamide and process for preparing the same |
Jun. 23, 2009 |
| 7534793 |
Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
May. 19, 2009 |
| 7531554 |
4-oxoquinoline compound and use thereof as HIV integrase inhibitor |
May. 12, 2009 |
| 7524862 |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
Apr. 28, 2009 |
| 7507750 |
Stabilized ascorbic acid derivative |
Mar. 24, 2009 |
| 7507749 |
Antitumor agents |
Mar. 24, 2009 |
| 7504416 |
4-substituted quinolines as antitumor agents |
Mar. 17, 2009 |
| 7488740 |
Substituted quinolin-4-ylamine analogues |
Feb. 10, 2009 |
| 7476680 |
Substituted heterocyclic compounds for treating multidrug resistance |
Jan. 13, 2009 |
| 7470709 |
Benzimidazole quinolinones and uses thereof |
Dec. 30, 2008 |
| 7468379 |
Inhibition of osteolytic lesions by SRC kinase inhibitors |
Dec. 23, 2008 |
| 7456196 |
Bicyclic-substituted amines as histamine-3 receptor ligands |
Nov. 25, 2008 |
| 7452887 |
Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
Nov. 18, 2008 |
| 7449479 |
Hepatitis C virus inhibitors |
Nov. 11, 2008 |
| 7442710 |
Substituted phenyl methanones |
Oct. 28, 2008 |
| 7425564 |
Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same |
Sep. 16, 2008 |
| 7417056 |
5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents |
Aug. 26, 2008 |
| 7414037 |
Hydrazide-containing CFTR inhibitor compounds and uses thereof |
Aug. 19, 2008 |
| RE40418 |
Treatment of neoplasms with CCI-779/EKB-569 combination |
Jul. 1, 2008 |
| 7384958 |
Quinoline inhibitors of cGMP phosphodiesterase |
Jun. 10, 2008 |
| 7378430 |
Quinoline inhibitors of cGMP phosphodiesterase |
May. 27, 2008 |
| 7371763 |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
May. 13, 2008 |
| 7365081 |
Indole derivatives and their use as medicaments |
Apr. 29, 2008 |
| 7354932 |
Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
Apr. 8, 2008 |
| 7348338 |
PPAR active compounds |
Mar. 25, 2008 |
| 7348340 |
N-type calcium channel antagonists for the treatment of pain |
Mar. 25, 2008 |
| RE40155 |
Methods for treatment of benign and malignant tumors, including lymphomas, leukemias, and leiomyomas |
Mar. 18, 2008 |
| 7342026 |
Substituted quinolines for the treatment of protozoa and retrovirus co-infections |
Mar. 11, 2008 |
| 7320989 |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
Jan. 22, 2008 |
| 7317024 |
Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof |
Jan. 8, 2008 |
| 7312230 |
Carboxylic acid derivatives as IP antagonists |
Dec. 25, 2007 |
| 7312233 |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
Dec. 25, 2007 |
| 7288559 |
Carboxamide spirohydantoin CGRP receptor antagonists |
Oct. 30, 2007 |
| 7268135 |
Biaryl sulfonamides and methods for using same |
Sep. 11, 2007 |
| 7265130 |
NPY Y5 antagonist |
Sep. 4, 2007 |
| 7265125 |
Neuropeptide Y antagonists |
Sep. 4, 2007 |
| 7265122 |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
Sep. 4, 2007 |
| 7265115 |
Diazabicyclic CNS active agents |
Sep. 4, 2007 |
| 7253184 |
4-Substituted quinolines as antitumor agents |
Aug. 7, 2007 |
| 7238707 |
Substituted pentanols, a process for their production and their use as anti-inflammatory agents |
Jul. 3, 2007 |
| 7235558 |
Inhibitors of the GPIb--vWF interaction, their preparation and use |
Jun. 26, 2007 |
| 7235259 |
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
Jun. 26, 2007 |
|
|
|
